Search Videos and More
National and International Accolades
Meet the bold clinicians and researchers whose work and perseverance push the edge of discovery, and have helped Fox Chase Cancer Center reach our 50th anniversary of excellence in cancer care.Fox Chase Cancer Center Appoints Dr. Jeffrey M. Farma Chair of Surgery
Fox Chase Cancer Center has appointed Jeffrey M. Farma, MD, FACS, to Chair of Surgery following a succession of leadership roles at the center.Fox Chase Cancer Center Opens First New Jersey Location in Voorhees
Fox Chase Cancer Center is proud to welcome patients to its newly opened office, which is located at 502 Centennial Boulevard, Suite 7, in Voorhees, New Jersey.Fox Chase Researcher and Former Chief Fellow Presents Findings on 5-Aminolevulinic Acid-Mediated Radiation Therapy to Reduce Tumor Size
“Radiodynamic therapy is a combined treatment technique of photodynamic therapy and radiation therapy that treats cancer using light and radiation,” said Dae-Myoung Yang, PhD, an Assistant Professor in the Department of Radiation Oncology at Fox Chase.A Prolific Career. An Auspicious Beginning.
As a genitourinary medical oncologist at Johns Hopkins, Jean Hoffman-Censits, MD, Associate Professor of Oncology and Urology, focuses on urothelial cancers of the bladder and upper tract, particularly women’s bladder cancer, which is often more aggressive than in men.Fox Chase Vision Illuminated by Real Nurses and Real Patients
When asked to present the keynote at this year’s ONA Summit, Real Nurses, Real Solutions: Breakthrough Strategies in Oncology Nursing Practice, Anna Liza Rodriguez, MSN, MHA, RN, OCN, NEA-BC, Chief Nursing Officer and Vice President, Nursing and Patient Care Services at Fox Chase Cancer Center, had the Fox Chase nursing staff, support staff, and patients bring the theme to life in a heartfelt video, demonstrating Fox Chase's vision and values.Temple University Hospital and Fox Chase Cancer Center Researchers Characterize HER2 Mutations in Patients With Lung Adenocarcinoma
Human epidermal growth factor 2 (HER2) mutations can be identified in up to 6% of non-small cell lung cancer cases where KRAS, EGFR, or ALK gene mutations are also found, according to the results of research from Temple University Hospital and Fox Chase Cancer Center presented today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.Fox Chase Researchers Present Data on Integrating Palliative Care Education Into Hematology-Oncology Fellowships
A new integrated palliative care rotation for hematology/oncology fellows improved their palliative care knowledge and skill confidence, according to results of a pilot study presented today by Fox Chase Cancer Center researchers at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.Integration, Location, Innovation: The Fox Chase-Temple Urologic Institute Leads the Way in Care
At Temple Health, we’re no stranger to firsts—whether that means performing a pioneering surgery, opening a new type of facility, or offering a groundbreaking treatment. That’s why it’s no surprise that we’re also leading the way in Urology care, reinforced by the recent launch of the Fox Chase-Temple Urologic Institute.Atlantic Regional Hematopathology Meeting
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this in-person education program is designed to focus on the role of molecular pathology and new technologies in diagnosis, prognostic stratification, and treatment of complex cases. Participants will gain insights into the significant changes, updates, and new categories in the 5th Edition of the World Health Organization Classification of Hematolympoid Tumors. Renowned invited pathologists and senior authors of the new WHO edition-Dr. Joseph Khoury, Dr. German Ott, and Dr. Sanam Loghavi-will discuss notable updates, modications, and new classifications in the morphology and molecular genetics of hematologic neoplasms that can be immediately applied in practice. As usual, there will be case-based podium presentations followed by discussion. A poster session will also take place.Fox Chase Researchers Examine Alternative Methods of Specialized Imaging Scans for Kidney Masses
In a study presented today at the American Urological Association (AUA) Annual Meeting 2024, researchers from Fox Chase Cancer Center showed that using numerical cutoffs as opposed to radiologist-read CT scans to determine whether a mass was likely cancerous did not yield more accurate results.Fox Chase Researchers Examine Effects of Radiation Therapy Timing on Lifespan of Artificial Urinary Sphincters
In a study presented today at the American Urological Association (AUA) Annual Meeting 2024, researchers at Fox Chase Cancer Center showed that in men who have undergone surgery for prostate cancer, the function of artificial urinary sphincters for stress urinary incontinence was improved when radiation was used as an adjuvant therapy rather than as a salvage therapy.